276 related articles for article (PubMed ID: 26109250)
1. Hepcidin and its potential clinical utility.
Miseta A; Nagy J; Nagy T; Poór VS; Fekete Z; Sipos K
Cell Biol Int; 2015 Nov; 39(11):1191-202. PubMed ID: 26109250
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin and iron disorders: new biology and clinical approaches.
Arezes J; Nemeth E
Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966
[TBL] [Abstract][Full Text] [Related]
4. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
[TBL] [Abstract][Full Text] [Related]
5. Current status of iron metabolism: Clinical and therapeutic implications.
Conde Diez S; de Las Cuevas Allende R; Conde García E
Med Clin (Barc); 2017 Mar; 148(5):218-224. PubMed ID: 28073521
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of hepcidin - the master regulator of iron metabolism.
Vyoral D; Jiri Petrak
Pharmacol Res; 2017 Jan; 115():242-254. PubMed ID: 27867027
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hepcidin to treat iron deregulation: potential clinical applications.
Blanchette NL; Manz DH; Torti FM; Torti SV
Expert Rev Hematol; 2016; 9(2):169-86. PubMed ID: 26669208
[TBL] [Abstract][Full Text] [Related]
8. [Role of iron metabolism-regulator hepcidin in perinatal iron homeostasis].
Balogh A; Bosze S; Horváti K; Mezo G; Kéki S; Nagy L; Bokodi G; Szabó M; Vásárhelyi B
Orv Hetil; 2010 Jan; 151(3):83-91. PubMed ID: 20061265
[TBL] [Abstract][Full Text] [Related]
9. Regulation of iron metabolism by hepcidin.
Nemeth E; Ganz T
Annu Rev Nutr; 2006; 26():323-42. PubMed ID: 16848710
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and disorders of iron metabolism.
Ganz T; Nemeth E
Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
[TBL] [Abstract][Full Text] [Related]
11. The iron-regulatory hormone hepcidin: a possible therapeutic target?
Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin: a real-time biomarker of iron need.
Hare DJ
Metallomics; 2017 Jun; 9(6):606-618. PubMed ID: 28470295
[TBL] [Abstract][Full Text] [Related]
13. Manipulation of the hepcidin pathway for therapeutic purposes.
Fung E; Nemeth E
Haematologica; 2013 Nov; 98(11):1667-76. PubMed ID: 24186312
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin and its role in inflammatory bowel disease.
Dudkowiak R; Neubauer K; Poniewierka E
Adv Clin Exp Med; 2013; 22(4):585-91. PubMed ID: 23986220
[TBL] [Abstract][Full Text] [Related]
15. Identification of The Canidae Iron Regulatory Hormone Hepcidin.
Mead MK; Claus M; Litton E; Smart L; Raisis A; Rossi G; Trengove RD; Gummer JPA
Sci Rep; 2019 Dec; 9(1):19400. PubMed ID: 31852911
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin, iron, and bacterial infection.
Barton JC; Acton RT
Vitam Horm; 2019; 110():223-242. PubMed ID: 30798814
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin in human iron disorders: diagnostic implications.
Kroot JJ; Tjalsma H; Fleming RE; Swinkels DW
Clin Chem; 2011 Dec; 57(12):1650-69. PubMed ID: 21989113
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.
Liu J; Sun B; Yin H; Liu S
Medicine (Baltimore); 2016 Apr; 95(14):e3150. PubMed ID: 27057839
[TBL] [Abstract][Full Text] [Related]
19. The role of hepcidin and haemojuvelin in the pathogenesis of iron disorders in patients with severe malnutrition.
Przybyszewska J; Żekanowska E
Ann Agric Environ Med; 2014; 21(2):336-8. PubMed ID: 24959785
[TBL] [Abstract][Full Text] [Related]
20. Role of hepcidin in physiology and pathophysiology. Emerging experimental and clinical evidence.
Wojciechowska M; Wisniewski OW; Kolodziejski P; Krauss H
J Physiol Pharmacol; 2021 Feb; 72(1):. PubMed ID: 34099582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
